| payload |
{"created_at":"2026-04-13T10:19:17.338 {"created_at":"2026-04-13T10:19:17.338896+00:00","signal_type":"news_headline_delta","source":"news_rss","url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNUWNZdk1Fb2FxU3BLYk9ReUZzS3dUcjdYVzRfUFEwRTV4bmhWbEVLaG9EaWVtZmRQWElMZjA1UVR1Qml4ZDZCSTNpVjZERVNEbUU0UlRteEhuYU9PUWNSbUk1c193TjhqMDJ4VGJNZktoYWJsdUJyMm1sTHdUZ0RXWkFxOGN0eHFjZXY1MGdJWlRoMDJZbVBlYW9RMWo2OVMyM29hUHN3QjVETzAwLW1MRDdQbE5PMG9ELXJHSlNsU1pjRm5leUM3Qm9hdW1BVUJRdXBGNE9qcEkxSWRGZkpHLTZ0TUJSZw?oc=5","value":{"fp":"94e2100bf44787bc","published_at":"2026-04-13T10:09:26+00:00","source":"StockStory","source_domain":"stockstory.org","source_url":"https://stockstory.org","summary":"Q4 Earnings Highs And Lows: Gilead Sciences (NASDAQ:GILD) Vs The Rest Of The Therapeutics Stocks StockStory","title":"Q4 Earnings Highs And Lows: Gilead Sciences (NASDAQ:GILD) Vs The Rest Of The Therapeutics Stocks - StockStory","url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNUWNZdk1Fb2FxU3BLYk9ReUZzS3dUcjdYVzRfUFEwRTV4bmhWbEVLaG9EaWVtZmRQWElMZjA1UVR1Qml4ZDZCSTNpVjZERVNEbUU0UlRteEhuYU9PUWNSbUk1c193TjhqMDJ4VGJNZktoYWJsdUJyMm1sTHdUZ0RXWkFxOGN0eHFjZXY1MGdJWlRoMDJZbVBlYW9RMWo2OVMyM29hUHN3QjVETzAwLW1MRDdQbE5PMG9ELXJHSlNsU1pjRm5leUM3Qm9hdW1BVUJRdXBGNE9qcEkxSWRGZkpHLTZ0TUJSZw?oc=5"}}... |